Meeder Asset Management’s Arcellx ACLX Stock Holding History

Meeder Asset Management’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45	Closed	-$3.45K	–	902
2024 Q4	$3.45K	Buy	+45	New	+$3.89K	﹤0.01%	867

Other funds holding ACLX

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Meeder Asset Management's ACLX Position: Q1 2025 in Review

Meeder Asset Management sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 45 shares — an estimated $3.45K sold.

Meeder Asset Management first reported a position in ACLX in Q4 2024 and held it in 1 quarter. The position peaked at $3.45K in Q4 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

Meeder Asset Management reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
Meeder Asset Management sold 45 Arcellx shares in Q1 2025, an estimated $3.45K.
Meeder Asset Management first reported a position in Arcellx in Q4 2024 and held it in 1 quarter.
Meeder Asset Management's Arcellx position peaked at $3.45K in Q4 2024.
197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on Meeder Asset Management's 13F filing for Q1 2025, filed 7 May 2025.